Seek Returns logo

ASND vs. PFE: A Head-to-Head Stock Comparison

Updated

Here’s a clear look at ASND and PFE, comparing key factors like performance, valuation metrics, dividends, and financial strength.

Company Overview

PFE’s market capitalization of 139.52 billion USD is significantly greater than ASND’s 10.31 billion USD, highlighting its more substantial market valuation.

With betas of 0.36 for ASND and 0.49 for PFE, both stocks show similar sensitivity to overall market movements.

ASND trades as an American Depositary Receipt (ADR), offering U.S. investors a convenient way to access its foreign-listed shares. In contrast, PFE is a standard domestic listing.

SymbolASNDPFE
Company NameAscendis Pharma A/SPfizer Inc.
CountryDKUS
SectorHealthcareHealthcare
IndustryBiotechnologyDrug Manufacturers - General
CEOMr. Jan Moller MikkelsenDr. Albert Bourla D.V.M., Ph.D.
Price170.8 USD24.54 USD
Market Cap10.31 billion USD139.52 billion USD
Beta0.360.49
ExchangeNASDAQNYSE
IPO DateJanuary 28, 2015June 1, 1972
ADRYesNo

Performance Comparison

This chart compares the performance of ASND and PFE over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).

Data is adjusted for dividends and splits.

  • ASND: $13708.97 (37.09%)
  • PFE: $9703.44 (-2.97%)

Valuation Metrics Comparison

This section compares the market valuation of ASND and PFE. Key takeaways regarding their valuation, when viewed within their industry context, are presented in the commentary that follows.

  • ASND’s Price-to-Earnings (P/E) ratio of -25.97 is negative, highlighting a lack of current profitability. This situation is a concern for its immediate financial performance and can impact investor confidence.
  • ASND’s Forward PEG ratio of -2.36 and PFE’s Forward PEG ratio of -3.73 are both in the negative range. For ASND, a negative PEG ratio often stems from negative current earnings or forecasts of declining earnings, making its valuation difficult to assess relative to growth. Similarly, PFE’s negative PEG suggests underlying issues with profitability or growth expectations, raising questions about its stock price compared to future prospects.
  • ASND’s Price-to-Book (P/B) ratio of -46.75 reflects a negative book value (meaning negative shareholder equity). This is a significant indicator of financial distress and raises substantial concerns about its solvency.
SymbolASNDPFE
Price-to-Earnings Ratio (P/E, TTM)-25.9717.70
Forward PEG Ratio (TTM)-2.36-3.73
Price-to-Sales Ratio (P/S, TTM)24.212.23
Price-to-Book Ratio (P/B, TTM)-46.751.54
EV-to-EBITDA (TTM)-37.7311.57
EV-to-Sales (TTM)25.103.19

Dividend Comparison

ASND currently offers no dividend yield, suggesting it may be reinvesting available cash back into the business for future growth, while PFE provides a 6.93% dividend yield, offering investors a component of income return.

SymbolASNDPFE
Dividend Yield (TTM)0.00%6.93%

Financial Strength Metrics Comparison

This section evaluates the financial strength of ASND and PFE. Noteworthy observations on their financial resilience, considered from an industry perspective, are detailed in the points that follow.

  • ASND’s Debt-to-Equity (D/E) ratio of -4.46 indicates negative shareholder equity. This is a significant red flag, suggesting its liabilities exceed its assets and posing a considerable threat to its long-term financial health.
  • ASND’s Interest Coverage Ratio (ICR) of -3.72 is negative. This implies its operating earnings are insufficient to meet its interest expenses, a serious situation that threatens its financial stability and capacity to honor debt commitments.
SymbolASNDPFE
Current Ratio (TTM)1.041.26
Quick Ratio (TTM)0.710.96
Debt-to-Equity Ratio (TTM)-4.460.68
Debt-to-Asset Ratio (TTM)0.800.29
Net Debt-to-EBITDA Ratio (TTM)-1.343.47
Interest Coverage Ratio (TTM)-3.725.00